kras mutation and glutathion Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Frontiers | KRAS mutation: The
Frontiers KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression Targeting KRAS Mutant Cancers with a Covalent G12C Specific Inhibitor: Cell The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy Molecular Cancer Springer Nature Link KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports
Pay in 4 interest-free payments of $5.65 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



